CA1288341C - Compositions physiologiquement actives - Google Patents

Compositions physiologiquement actives

Info

Publication number: CA1288341C
Authority: CA; Canada
Prior art keywords: hormone; fragment; growth; hgh; formulation
Prior art date: 1983-08-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

CA000543109A

Other languages

English (en)

Inventor

Roger Aston

Juraj Ivanyi

Andrew Thomas Holder

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Wellcome Foundation Ltd

Original Assignee

Wellcome Foundation Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-08-17

Filing date

1987-07-27

Publication date

1991-09-03

1983-08-17 Priority claimed from GB838322115A external-priority patent/GB8322115D0/en

1983-08-25 Priority claimed from GB08322816A external-priority patent/GB2145696B/en

1984-08-16 Priority claimed from CA000461152A external-priority patent/CA1259923A/fr

1987-07-27 Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd

1991-09-03 Application granted granted Critical

1991-09-03 Publication of CA1288341C publication Critical patent/CA1288341C/fr

2008-09-03 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

239000000203 mixture Substances 0.000 title claims abstract description 35
229940088597 hormone Drugs 0.000 claims abstract description 95
239000005556 hormone Substances 0.000 claims abstract description 95
239000012634 fragment Substances 0.000 claims abstract description 44
238000009472 formulation Methods 0.000 claims abstract description 31
241000251539 Vertebrata <Metazoa> Species 0.000 claims abstract description 29
230000012010 growth Effects 0.000 claims abstract description 26
108010051696 Growth Hormone Proteins 0.000 claims abstract description 22
239000000122 growth hormone Substances 0.000 claims abstract description 22
230000001105 regulatory effect Effects 0.000 claims abstract description 15
239000002671 adjuvant Substances 0.000 claims abstract description 10
230000004044 response Effects 0.000 claims abstract description 9
239000003937 drug carrier Substances 0.000 claims abstract description 6
230000001900 immune effect Effects 0.000 claims abstract description 6
238000002360 preparation method Methods 0.000 claims description 10
239000000381 Placental Lactogen Substances 0.000 claims description 9
102000004576 Placental Lactogen Human genes 0.000 claims description 9
108010003044 Placental Lactogen Proteins 0.000 claims description 9
108010057464 Prolactin Proteins 0.000 claims description 6
102100024819 Prolactin Human genes 0.000 claims description 6
229940097325 prolactin Drugs 0.000 claims description 6
239000008194 pharmaceutical composition Substances 0.000 claims description 3
230000006651 lactation Effects 0.000 claims description 2
102100038803 Somatotropin Human genes 0.000 claims 4
241000124008 Mammalia Species 0.000 claims 2
238000004519 manufacturing process Methods 0.000 claims 1
241001465754 Metazoa Species 0.000 abstract description 23
102000018997 Growth Hormone Human genes 0.000 abstract description 18
108010000521 Human Growth Hormone Proteins 0.000 description 55
102000002265 Human Growth Hormone Human genes 0.000 description 55
239000000854 Human Growth Hormone Substances 0.000 description 54
241000699670 Mus sp. Species 0.000 description 31
230000000694 effects Effects 0.000 description 19
210000000845 cartilage Anatomy 0.000 description 15
238000000034 method Methods 0.000 description 15
230000003389 potentiating effect Effects 0.000 description 15
208000021017 Weight Gain Diseases 0.000 description 14
230000004584 weight gain Effects 0.000 description 13
235000019786 weight gain Nutrition 0.000 description 13
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
102000011923 Thyrotropin Human genes 0.000 description 12
108010061174 Thyrotropin Proteins 0.000 description 12
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
210000001519 tissue Anatomy 0.000 description 12
239000011780 sodium chloride Substances 0.000 description 11
239000007924 injection Substances 0.000 description 10
238000002347 injection Methods 0.000 description 10
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 9
239000002953 phosphate buffered saline Substances 0.000 description 9
238000003556 assay Methods 0.000 description 8
230000037396 body weight Effects 0.000 description 7
241000272201 Columbiformes Species 0.000 description 6
241000282414 Homo sapiens Species 0.000 description 6
102000004877 Insulin Human genes 0.000 description 6
241001494479 Pecora Species 0.000 description 6
210000004027 cell Anatomy 0.000 description 6
235000005911 diet Nutrition 0.000 description 6
230000037213 diet Effects 0.000 description 6
229940125396 insulin Drugs 0.000 description 6
230000001983 lactogenic effect Effects 0.000 description 6
230000003278 mimic effect Effects 0.000 description 6
210000001685 thyroid gland Anatomy 0.000 description 6
108090001061 Insulin Proteins 0.000 description 5
241000699666 Mus <mouse, genus> Species 0.000 description 5
230000009471 action Effects 0.000 description 5
230000007812 deficiency Effects 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
230000003601 intercostal effect Effects 0.000 description 5
241001515942 marmosets Species 0.000 description 5
239000000463 material Substances 0.000 description 5
210000004877 mucosa Anatomy 0.000 description 5
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
QTCANKDTWWSCMR-UHFFFAOYSA-N costic aldehyde Natural products C1CCC(=C)C2CC(C(=C)C=O)CCC21C QTCANKDTWWSCMR-UHFFFAOYSA-N 0.000 description 4
ISTFUJWTQAMRGA-UHFFFAOYSA-N iso-beta-costal Natural products C1C(C(=C)C=O)CCC2(C)CCCC(C)=C21 ISTFUJWTQAMRGA-UHFFFAOYSA-N 0.000 description 4
108090000623 proteins and genes Proteins 0.000 description 4
102000005962 receptors Human genes 0.000 description 4
108020003175 receptors Proteins 0.000 description 4
239000000126 substance Substances 0.000 description 4
229910021653 sulphate ion Inorganic materials 0.000 description 4
108010001857 Cell Surface Receptors Proteins 0.000 description 3
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
206010062767 Hypophysitis Diseases 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
239000000427 antigen Substances 0.000 description 3
108091007433 antigens Proteins 0.000 description 3
102000036639 antigens Human genes 0.000 description 3
230000008859 change Effects 0.000 description 3
230000001186 cumulative effect Effects 0.000 description 3
230000000366 juvenile effect Effects 0.000 description 3
102000006240 membrane receptors Human genes 0.000 description 3
210000003635 pituitary gland Anatomy 0.000 description 3
235000018102 proteins Nutrition 0.000 description 3
102000004169 proteins and genes Human genes 0.000 description 3
238000003127 radioimmunoassay Methods 0.000 description 3
210000002966 serum Anatomy 0.000 description 3
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
241000894007 species Species 0.000 description 3
230000003442 weekly effect Effects 0.000 description 3
NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 2
241000271566 Aves Species 0.000 description 2
238000011725 BALB/c mouse Methods 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
108010044091 Globulins Proteins 0.000 description 2
102000006395 Globulins Human genes 0.000 description 2
206010018498 Goitre Diseases 0.000 description 2
101000687438 Homo sapiens Prolactin Proteins 0.000 description 2
108060003951 Immunoglobulin Proteins 0.000 description 2
102000014150 Interferons Human genes 0.000 description 2
108010050904 Interferons Proteins 0.000 description 2
206010028665 Myxoedema Diseases 0.000 description 2
241000700159 Rattus Species 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
230000003213 activating effect Effects 0.000 description 2
230000002776 aggregation Effects 0.000 description 2
238000004220 aggregation Methods 0.000 description 2
230000000890 antigenic effect Effects 0.000 description 2
230000008901 benefit Effects 0.000 description 2
210000000038 chest Anatomy 0.000 description 2
230000001684 chronic effect Effects 0.000 description 2
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
235000018417 cysteine Nutrition 0.000 description 2
201000008496 endemic goiter Diseases 0.000 description 2
210000003372 endocrine gland Anatomy 0.000 description 2
239000000284 extract Substances 0.000 description 2
230000003054 hormonal effect Effects 0.000 description 2
102000018358 immunoglobulin Human genes 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
229940079322 interferon Drugs 0.000 description 2
210000005075 mammary gland Anatomy 0.000 description 2
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
235000013336 milk Nutrition 0.000 description 2
239000008267 milk Substances 0.000 description 2
210000004080 milk Anatomy 0.000 description 2
208000003786 myxedema Diseases 0.000 description 2
YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
208000003068 pituitary dwarfism Diseases 0.000 description 2
238000011160 research Methods 0.000 description 2
230000000717 retained effect Effects 0.000 description 2
239000012064 sodium phosphate buffer Substances 0.000 description 2
239000000243 solution Substances 0.000 description 2
210000001562 sternum Anatomy 0.000 description 2
229960005486 vaccine Drugs 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
238000005303 weighing Methods 0.000 description 2
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
108010042708 Acetylmuramyl-Alanyl-Isoglutamine Proteins 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
206010006895 Cachexia Diseases 0.000 description 1
XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
206010013883 Dwarfism Diseases 0.000 description 1
102000001301 EGF receptor Human genes 0.000 description 1
108060006698 EGF receptor Proteins 0.000 description 1
102400001368 Epidermal growth factor Human genes 0.000 description 1
101800003838 Epidermal growth factor Proteins 0.000 description 1
244000187656 Eucalyptus cornuta Species 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
241000282412 Homo Species 0.000 description 1
102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
102100023915 Insulin Human genes 0.000 description 1
108010001127 Insulin Receptor Proteins 0.000 description 1
102000015696 Interleukins Human genes 0.000 description 1
108010063738 Interleukins Proteins 0.000 description 1
208000022757 Isolated thyroid-stimulating hormone deficiency Diseases 0.000 description 1
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
102100038609 Lactoperoxidase Human genes 0.000 description 1
108010023244 Lactoperoxidase Proteins 0.000 description 1
102000008072 Lymphokines Human genes 0.000 description 1
108010074338 Lymphokines Proteins 0.000 description 1
108700018351 Major Histocompatibility Complex Proteins 0.000 description 1
241001529936 Murinae Species 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
101100219321 Oryza sativa subsp. japonica CYP85A1 gene Proteins 0.000 description 1
101150112800 PE35 gene Proteins 0.000 description 1
108090000526 Papain Proteins 0.000 description 1
102000007079 Peptide Fragments Human genes 0.000 description 1
108010033276 Peptide Fragments Proteins 0.000 description 1
239000004365 Protease Substances 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical class [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
108090000787 Subtilisin Proteins 0.000 description 1
241000282887 Suidae Species 0.000 description 1
102000018594 Tumour necrosis factor Human genes 0.000 description 1
108050007852 Tumour necrosis factor Proteins 0.000 description 1
208000026928 Turner syndrome Diseases 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
239000008272 agar Substances 0.000 description 1
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
229910021502 aluminium hydroxide Inorganic materials 0.000 description 1
239000012491 analyte Substances 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
230000002052 anaphylactic effect Effects 0.000 description 1
210000003484 anatomy Anatomy 0.000 description 1
238000004166 bioassay Methods 0.000 description 1
238000009835 boiling Methods 0.000 description 1
108010006025 bovine growth hormone Proteins 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
239000000969 carrier Substances 0.000 description 1
238000012656 cationic ring opening polymerization Methods 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
238000004440 column chromatography Methods 0.000 description 1
210000004246 corpus luteum Anatomy 0.000 description 1
ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000002950 deficient Effects 0.000 description 1
230000000994 depressogenic effect Effects 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
238000009826 distribution Methods 0.000 description 1
229960001484 edetic acid Drugs 0.000 description 1
230000002124 endocrine Effects 0.000 description 1
229940116977 epidermal growth factor Drugs 0.000 description 1
210000000981 epithelium Anatomy 0.000 description 1
239000012530 fluid Substances 0.000 description 1
235000019253 formic acid Nutrition 0.000 description 1
239000007973 glycine-HCl buffer Substances 0.000 description 1
102000035122 glycosylated proteins Human genes 0.000 description 1
108091005608 glycosylated proteins Proteins 0.000 description 1
230000036541 health Effects 0.000 description 1
108091008039 hormone receptors Proteins 0.000 description 1
210000004408 hybridoma Anatomy 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
230000003053 immunization Effects 0.000 description 1
238000002649 immunization Methods 0.000 description 1
238000003119 immunoblot Methods 0.000 description 1
230000005847 immunogenicity Effects 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
238000007689 inspection Methods 0.000 description 1
229940047122 interleukins Drugs 0.000 description 1
239000007928 intraperitoneal injection Substances 0.000 description 1
150000002497 iodine compounds Chemical class 0.000 description 1
108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 1
229940057428 lactoperoxidase Drugs 0.000 description 1
235000020997 lean meat Nutrition 0.000 description 1
230000001592 luteinising effect Effects 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
230000000566 mammotropic effect Effects 0.000 description 1
238000005259 measurement Methods 0.000 description 1
235000013372 meat Nutrition 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
210000003097 mucus Anatomy 0.000 description 1
230000021332 multicellular organism growth Effects 0.000 description 1
BSOQXXWZTUDTEL-ZUYCGGNHSA-N muramyl dipeptide Chemical compound OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O BSOQXXWZTUDTEL-ZUYCGGNHSA-N 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
229960005030 other vaccine in atc Drugs 0.000 description 1
229940055729 papain Drugs 0.000 description 1
235000019834 papain Nutrition 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
230000017363 positive regulation of growth Effects 0.000 description 1
244000144977 poultry Species 0.000 description 1
230000001376 precipitating effect Effects 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
239000000047 product Substances 0.000 description 1
239000001397 quillaja saponaria molina bark Substances 0.000 description 1
239000000700 radioactive tracer Substances 0.000 description 1
230000009467 reduction Effects 0.000 description 1
239000003488 releasing hormone Substances 0.000 description 1
230000008439 repair process Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
229930182490 saponin Natural products 0.000 description 1
150000007949 saponins Chemical class 0.000 description 1
238000009738 saturating Methods 0.000 description 1
230000028327 secretion Effects 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
210000004872 soft tissue Anatomy 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
210000004989 spleen cell Anatomy 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
238000010972 statistical evaluation Methods 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
239000008399 tap water Substances 0.000 description 1
235000020679 tap water Nutrition 0.000 description 1
238000012360 testing method Methods 0.000 description 1
229960000814 tetanus toxoid Drugs 0.000 description 1
229940034208 thyroxine Drugs 0.000 description 1
XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
238000012546 transfer Methods 0.000 description 1
238000012762 unpaired Student’s t-test Methods 0.000 description 1
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
208000016261 weight loss Diseases 0.000 description 1
230000004580 weight loss Effects 0.000 description 1

Landscapes

Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

CA000543109A 1983-08-17 1987-07-27 Compositions physiologiquement actives Expired - Lifetime CA1288341C (fr)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
GB838322115A GB8322115D0 (en)	1983-08-17	1983-08-17	Physiologically active compositions
GB8322115		1983-08-17
GB08322816A GB2145696B (en)	1981-06-05	1983-08-25	Feeding and transporting paper sheets
GB8322816		1983-08-25
CA000461152A CA1259923A (fr)	1983-08-17	1984-08-16	Compositions a activite physiologique

Publications (1)

Publication Number	Publication Date
CA1288341C true CA1288341C (fr)	1991-09-03

Family

ID=27167458

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000543109A Expired - Lifetime CA1288341C (fr)	1983-08-17	1987-07-27	Compositions physiologiquement actives

Country Status (1)

Country	Link
CA (1)	CA1288341C (fr)

1987
- 1987-07-27 CA CA000543109A patent/CA1288341C/fr not_active Expired - Lifetime

Legal Events

Date	Code	Title	Description
2008-09-03	MKEX	Expiry

Publication	Publication Date	Title
EP0137234B1 (fr)	1990-10-10	Compositions physiologiquement actives
US4599229A (en)	1986-07-08	Method of promoting animal growth using antibodies against somatostatin
Kerr et al.	1990	Effects of passive immunization of growing guinea-pigs with an insulin-like growth factor-I monoclonal antibody
DE3851455T2 (de)	1995-02-02	Biologisch wirksame Moleküle.
Deckert et al.	1970	The antigenicity of pig insulin
CA1288341C (fr)	1991-09-03	Compositions physiologiquement actives
JPH03503403A (ja)	1991-08-01	生物学的に活性な分子
JPS63214667A (ja)	1988-09-07	成長促進に有効なモノクローナル抗体
DE3852588T2 (de)	1995-05-11	Biologisch aktive Moleküle.
JPH02504512A (ja)	1990-12-20	アンジオゲニンに対する抗体：免疫療法剤
NZ196125A (en)	1985-02-28	Increasing fecundity of sheep or goats
US5401829A (en)	1995-03-28	Biologically active molecules
Page et al.	1990	Modulation of the biological activity of thyrotrophin by anti-human thyrotrophin monoclonal antibodies
Bleeker et al.	1995	Evaluation of the immunogenicity of polymerized hemoglobin solutions in a rabbit model
Wang et al.	1996	Immunological effect of a synthetic growth hormone peptide on the growth performance in swine
JP2000508293A (ja)	2000-07-04	Ｆｓｈ作用の促進に有用な新規なペプチド
JPS60120824A (ja)	1985-06-28	ホルモン活性処方物
Hirooka et al.	1993	In vivo stimulation of thyroid hormone release by rabbit antibodies with thyroid stimulating activity raised against the mutated receptor peptide TSH-R-HIS17
Morris et al.	1991	Effect of immunizing prepuberal lambs of low and high ovulation rate genotypes with inhibin partially purified from bovine follicular fluid
Bick et al.	1990	Antibody responses to recombinant bovine somatotropin in dairy cattle
AU7642387A (en)	1988-01-29	Composition and method for immunological castration and spaying
PL163277B1 (en)	1994-03-31	Method of obtaining peptides
JPS60107567A (ja)	1985-06-13	トリ由来カルシトニンの微量検定方法